Phase 2a Evaluation of Safety, Tolerability, and Pharmacokinetics of PLN-74809 in Patients With Primary Sclerosing Cholangitis (PSC)
Study sponsor: Pliant Therapeutics, Inc. · PLRX
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2024-02-26Actual
Enrollment · participants121Actual
Source updated2026-01-23Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.